MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Improvement of foot progression in cervical dystonia using osteopathic manipulative medicine

    J.D. Mancini, Z. Oliff, A. LaRosa, S. Mody, R. Abu-Sbaih, A. Leder (Old Westbury, NY, USA)

    Objective: To determine if osteopathic manipulative medicine (OMM) can improve gait biomechanics in people with cervical dystonia (CD). Background: CD is a neurological disorder characterized…
  • 2016 International Congress

    Cervical dystonia associated to Wallenberg syndrome

    I. Parees, M. Romeral, D. Mayo, D. Toledo, M.E. Garcia, J. Matias-Guiu, A. Marcos, J. Porta-Etessam (Madrid, Spain)

    Objective: To describe, for the first time, a patient who developed cervical dystonia with signs and symptoms of a Wallenberg syndrome. Background: Secondary cervical dystonia…
  • 2016 International Congress

    Heterozygous TUBB4A knock-out impairs mitochondrial motility in human neuronal model of DYT4

    V. Krajka, F. Vulinovic, P. Seibler, K. Lohmann, C. Klein, A. Rakovic (Luebeck, Germany)

    Objective: To study the role of tubulin beta 4A (TUBB4A) in mitochondrial motility in isogenic induced pluripotent stem cells (iPSC)-derived neurons. Background: Heterozygous mutations in…
  • 2016 International Congress

    Assessment of need for treatment with botulinum toxin type A in cervical dystonia patients

    C.L. Vaughan, G.T. Stebbins, C.L. Comella (Charleston, SC, USA)

    Objective: To prospectively assess the interval in weeks between injection of botulinum toxin A (BoNTA) and patient-perceived need for the next injection for treatment of…
  • 2016 International Congress

    Clinical and molecular features of DYT1 primary dystonia in a Peruvian population

    M. Inca-Martinez, K. Milla-Neyra, C.C. Cosentino, N. Mori, V. Marca, M. Flores, E. Guevara-Silva, Y. Nuñez-Coronado, C.M. Vasquez, L. Torres-Ramirez, P. Mazzetti, M. Cornejo-Olivas (Lima, Peru)

    Objective: To associate clinical data of dystonia patients with the TOR1-A gene mutation in Peru. Background: DYT1 dystonia is a severe generalized form of early-onset…
  • 2016 International Congress

    Pseudodystonic upper limb secondary to thalamic lesions: Usefulness of ultrasound-guided botulinum toxin treatment

    C. Costa, P. Pita Lobo (Amadora, Portugal)

    Objective: Case reports. Background: Although botulinum toxin is routinely used as first-line treatment for focal dystonias, little is known about its usefulness in the treatment…
  • 2016 International Congress

    Motor variability and learning indices in DYT1 dystonia

    A. Sadnicka, A. Stevenson, J.C. Rothwell, K.P. Bhatia, J. Galea, M.J. Edwards (London, United Kingdom)

    Objective: To examine motor variability in DYT1 dystonia and its interaction with subtypes of motor learning. Background: In healthy subjects it is now known that…
  • 2016 International Congress

    Probable REM sleep behaviour disorder and detrusor overactivity in primary cervical dystonia- A case report

    S.L. Bhadran, M.G.J. Jacob, S. Kripal (Thrissur, India)

    Objective: To report two atypical associations of pRBD and DO we came across with a case of primary cervical dystonia. Background: RBD (REM sleep Behaviour…
  • 2016 International Congress

    Axial prominent, delayed onset dystonia in cerebral palsy: Highlights on a distinct phenotype with favorable outcome following deep brain stimulation

    L. Cif, V. Gonzalez Martinez, E. Sanrey, E. Nerrant, M. Ros, F. Cyprien, E. Chan Seng, T. Roujeau, P. Coubes (Montpellier, France)

    Objective: To report on a subgroup of DCP patients with delayed onset of dystonia who received DBS therapy. Background: Dyskinetic cerebral palsy (DCP) is the…
  • 2016 International Congress

    Syndrome of dystonia-parkinsonism is a complication of cyclosporine A treatment and may be irreversible

    P. Miklavcic, S. Avcin, J. Jazbec, T. Vipotnik Vesnaver, B. Todorova, M. Trost, M. Kojovic (Ljubljana, Slovenia)

    Objective: To describe the clinical and imaging features of patients who developed dystonia-parkinsonism syndrome due to cyclosporine A(CsA). Background: CsA is an immunosuppressant widely used…
  • « Previous Page
  • 1
  • …
  • 1511
  • 1512
  • 1513
  • 1514
  • 1515
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25128 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley